Skip to main content

Animations

MJFF Publications

5831 - 5840 of 6403 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2023
  • 2024
  • 2024
  • 2018
  • 2021
  • 2018
  • 2022
  • 2017
  • Summary Details
    OPEN
    Title: Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12632
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.003
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51753
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach
    Journal Name: Bioengineering
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/bioengineering12010011
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.010
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26089
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.05.018
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-022-02523-3
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897
    Citation Count: 85
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.